The telemedicine stock should be back on your radar after the recent quarterly results!
Hims & Hers is in a strategic growth phase. Management is consciously prioritizing long-term expansion over short-term profit maximization.
Reading Time: 1 minute
The stock of Hims & Hers marks a decisive turning point with its recent quarterly results, making it interesting for long-term investors. The most impressive metric is the consistently strong revenue growth. With a quarterly revenue of $599 million (Q3 2025), Hims & Hers exceeded expectations and achieved an increase of nearly 50% compared to the same quarter last year. This explosive growth is primarily driven by the increased subscriber base of approximately 2.5 million, as well as a rising average monthly revenue per customer (AUPC)....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
